Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model

The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species

(2012) Jessica Bien et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biomolecular coronas provide the biological identity of nanosized materials

(2012) Marco P. Monopoli et al.   Nature Nanotechnology

Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model

(2012) Sylvia Wagner et al.   PLoS One

Chemical Biology, Molecular Mechanism and Clinical Perspective of γ - Secretase Modulators in Alzheimers Disease

(2011) Bruno Bulic et al.   Current Neuropharmacology

Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragmentsin Vivo

(2011) Tamara Jefferson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

(2011) Davide Brambilla et al.   Nanomedicine-Nanotechnology Biology and Medicine

Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system

(2010) Gabriel A. Silva   Annals of the New York Academy of Sciences

Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System

(2010) Emanuela Fabiola Craparo et al.   CNS Neuroscience & Therapeutics

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

(2010) Jasjeet Kaur Sahni et al.   JOURNAL OF CONTROLLED RELEASE

Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer’s disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure

(2010) Stefanie Hahn et al.   JOURNAL OF NEUROCHEMISTRY

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model

(2010) Sylvia Wagner et al.   PLoS One

Enhanced drug targeting by attachment of an anti αv integrin antibody to doxorubicin loaded human serum albumin nanoparticles

(2009) Sylvia Wagner et al.   BIOMATERIALS

Biodegradable polymeric nanoparticles based drug delivery systems

(2009) Avnesh Kumari et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial

(2009) Robert C. Green   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

(2009) Anja Zensi et al.   JOURNAL OF CONTROLLED RELEASE

The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

(2009) John Hardy   JOURNAL OF NEUROCHEMISTRY

Polymeric nanoparticles for the drug delivery to the central nervous system

(2008) Giovanni Tosi et al.   Expert Opinion on Drug Delivery